Atrial Fibrillation and Hemodialysis – Should we Anticoagulate These Patients? Ischemic Versus Hemorrhagic Risk
Saved in:
Format: | Digital revista |
---|---|
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia
2022
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472022000600757 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemorrhagic Versus Ischemic Risk in Patients with Atrial Fibrillation on Hemodialysis
by: Sousa,Mariana, et al.
Published: (2022) -
Challenges for Anticoagulation in Atrial Fibrillation
by: Bronchtein,Ana Inês da Costa
Published: (2020) -
Prevalence of oral anticoagulation in atrial fibrillation
by: Bartholomay,Eduardo, et al.
Published: (2014) -
Prevention of thromboembolic events in patients with atrial fibrillation – new anticoagulants
by: Campos,Alexandre Holthausen, et al.
Published: (2011) -
Oral anticoagulation in patients with atrial fibrillation and end-stage kidney disease
by: Azevedo,Tânia B., et al.
Published: (2022)